Combination gemcitabine + cisplatin therapy for recurrent ovarian cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1376, 2003-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimal therapy for platinum-resistant recurrent ovarian cancer: doxorubicin, gemcitabine or topotecan?

By Pectasides Dimitris   Psyrri Amanda   Pectasides Melina   Economopoulos Theofanis  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 8, 2006-06 ,pp. : 975-987

Informa Healthcare

Access to resources Recommend Favorite

Gemcitabine enhances carboplatin for recurrent ovarian cancer

By  

Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Combination therapy with erlotinib and cisplatin is effective in patients with recurrent or metastatic squamous cell cancer of the head and neck

By  

Inpharma, Vol. 1, Iss. 1591, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study

By Morgan Robert  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 723-728

Springer Publishing Company

Access to resources Recommend Favorite

Combination therapy with gemcitabine and docetaxel is effective in patients with advanced urothelial cancer

By  

Inpharma, Vol. 1, Iss. 1416, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite